Skip to main content
. 2020 Nov 12;12(4):375–386. doi: 10.1007/s40506-020-00242-5

Table 2.

Immunogenicity of JEV vaccines

JEV vaccine Seroconversion Reference
Cases/total Rate (95% CI) %
JEV-I(PHK) pooled 71/80 88.75 (79.72–94.73) [25]
JEV-I(Vero) pooled 375/468 86.49 (83.64–89.36) [25]
JEV-L pooled 822/972 83.52 (80.90–86.14) [25]
SA14-14-2 LAV 116/117 99.1 (95.3; 100) [32]
SA14-14-2 LAV 82/90 91 [36]
JE-CV 119/119 100 (96.9; 100) [32]